Kidney transplantation offers recipients superior outcomes and improved quality of life compared with dialysis. However, the need for ongoing immunosuppression places recipients at increased risk of certain forms of cancer. Screening and early detection of precancerous lesions are one of the few proven ways to lower the risk of cancer morbidity and mortality in the transplant population. Women have additional barriers to cancer screening services globally, especially in low- and middle-income countries as well as within certain disadvantaged groups in high-income countries. There is a dearth of published data on screening guidelines and policies on post-transplant malignancy in female recipients. It is vital that health care providers and patients are educated regarding the risks of cancer at all post-transplant stages and that the recommended screening policies are adhered to in order to reduce associated morbidity and mortality in this at-risk group.
Keyphrases
- kidney transplantation
- papillary thyroid
- healthcare
- squamous cell
- end stage renal disease
- chronic kidney disease
- public health
- primary care
- squamous cell carcinoma
- type diabetes
- systematic review
- lymph node metastasis
- newly diagnosed
- prognostic factors
- randomized controlled trial
- risk assessment
- peritoneal dialysis
- adipose tissue
- childhood cancer
- climate change
- electronic health record
- health insurance
- human health
- health information